A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies
A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies
Active, not recruiting · NCT04606381 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies | neoplasm | Active, not recruiting | Phase 1 | 2026-09-25 | NCT04606381 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai Medical Center | West Hollywood | United States | 2 |
| Chungbuk National University Hospital | Cheongju-si | South Korea | 47 |
| Community Health Network | Indianapolis | United States | 5 |
| Langone Health at NYC University, NYU School of Medicine | New York | United States | 3 |
| Providence Portland Medical Center | Portland | United States | 324 |
| Royal Marsden Hospital | Sutton | United Kingdom | 29 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 57 |
| Severance Hospital Yonsei University Health System | Seoul | South Korea | 90 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 113 |
| University Health Network | Toronto | Canada | 52 |